期刊文献+

RNA干扰Dub3表达对鼻咽癌细胞增殖和凋亡的影响 被引量:4

Effect of siRNA targeting Dub3 gene on the proliferation and apoptosis of human nasopharyngeal carcinoma CNE-2 cells
下载PDF
导出
摘要 目的探讨小干扰RNA(siRNA)靶向抑制去泛素化酶3(Dub3)基因表达对人鼻咽癌CNE-2细胞增殖、凋亡及细胞周期的影响。方法优化siRNA转染条件,将2条靶向抑制Dub3基因的siRNA载体片段(siRNA-1、siRNA-2)分别高效转染人鼻咽癌CNE-2细胞,同时设转染无义序列的空转染组及无任何处理的对照组。分别于转染24、48、72、96 h后采用实时定量PCR(q PCR)检测Dub3表达水平以筛选抑制率高的感染载体用于后续试验。噻唑蓝法检测各组转染24、48、72、96 h后的增殖抑制率,流式细胞术检测各组转染48、96 h后的细胞凋亡和细胞周期情况,采用Western blotting检测各组转染96 h后细胞分裂周期蛋白25A(Cdc25A)的表达情况。结果转染组的Dub3 mRNA水平均低于空转染组和对照组(P<0.05),且选择干扰效率高的siRNA-1载体进行功能学研究;与其余两组相比,抑制组转染后的增殖抑制率、凋亡率及caspase-3活化率均升高,且G_0/G_1期细胞比例升高,但S期和G_2/M期细胞比例均降低,以上差异均有统计学意义(P<0.05);抑制组转染后的Cdc25A水平降低,与空载体组和对照组的差异有统计学意义(P<0.05)。空载体组和对照组以上指标的差异均无统计学意义(P>0.05)。结论通过siRNA抑制Dub3基因表达可抑制鼻咽癌细胞的增殖并诱导凋亡和细胞周期阻滞,对鼻咽癌的防治有一定价值。 Objective To explore the effect of siRNA targeting deubiquitinating enzyme 3( Dub 3) gene on the proliferation and apoptosis of human nasopharyngeal carcinoma CNE-2 cells. Methods After the optimization of the transfection conditions,2 siRNA vector fragments( siRNA-1 and siRNA-2) targeting Dub3 gene were effectively transfected into CNE-2 cells,respectively. There were empty transfection group whose cells were transfected with the antisense sequence and control group without any treatment. The Dub3 expression levels were detected by real-time quantitative PCR( q PCR) at 24,48,72 and 96 h after transfection,and the siRNA vector with the higher inhibition rate was used for the following experiments. Thiazolyl blue was used to detect the proliferation inhibition rates at 24,48,72,96 h after transfection. The apoptosis and cell cycle of the cells were detected by flow cytometry after 48 and96 h. The expression of cell division cycle 25A( Cdc25A) after 96 h was detected by Western blotting. Results The levels of mRNA Dub3 in the transfection group were lower than those in the empty transfection group and the control group( P〈0. 05). Since the interference efficiency of the siRNA-1 fragment was higher than that of the siRNA-2,so the subsequent experiments chose the siRNA-1 fragment. Compared with other two groups,the proliferation inhibitory rates,apoptosis rates and caspase-3 activation rates together with the proportion of cells in G0/ G1 phase increased,but the proportion of cells in S and G2/ M phase decreased in inhibition group with statistically significant difference( P〈0. 05); After transfection,the levels of Cdc25 A were decreased in inhibition group versus other groups( P〈0. 05). Conclusion The inhibition of Dub3 gene expression by siRNA can inhibit the proliferation and induce apoptosis and cell cycle arrest,and it can be valuable for the prevention and treatment of nasopharyngeal carcinoma.
出处 《临床肿瘤学杂志》 CAS 2015年第11期977-982,共6页 Chinese Clinical Oncology
关键词 干扰RNA 去泛素化酶3 鼻咽癌 增殖 凋亡 Small interfering RNA Deubiquitinating enzyme 3 Nasopharyngeal carcinoma Proliferation Apoptosis
  • 相关文献

参考文献14

  • 1龚修云,金风,吴伟莉,陈海霞,李媛媛,陈潇潇,何明媛,刘梅.西妥昔单抗联合顺铂同步三维适形调强放疗治疗初治局部晚期鼻咽癌的临床观察[J].临床肿瘤学杂志,2012,17(10):919-922. 被引量:16
  • 2Qu Y, Chen Y, Yu H, et al. Survival and prognostic analysis of primary nasopharyngeal carcinoma in North China[ J. Clin Lab, 2015, 61(7) :699-708.
  • 3Lin SC, Gan ZH, Yao Y, et al. The prognostic value of forkhead box P3 expression in operable breast cancer: a large-scale meta- analysis[ J/OL]. PLoS One, 2015, 10 (8) [ 2015-08-31 1. http ://www. nebi. nlm. nih. gov/pmc/articles/PMC4549287.
  • 4Choi HI-/, Phan L, Chou PC, et al. COP! enhances ubiquitin- mediated degradation of p27xiO to promote cancer cell growth [ J ]. Oncotarget, 2015, 6 (23) : 19721 - 19734.
  • 5Delgado-Daz MR, Martin Y, Berg A, et al. Dub3 controls DNA damage signalling by direct deubiquitination of H2AX [ J ]. Moi Oncol, 2014, 8(5) :884-893.
  • 6Forte S, Pagliuca A, Maniscalchi ET, et al. Gene expression a- nalysis of PTEN positive glioblastoma stem cells identifies DUB3 and Weel modulation in a cell differentiation model [ J/OL ].PLoS One, 2013, 8(12)[2015-05-26]. http://www.ncbi.nlm. nih.gov/pme/artieles/PMC3861258.
  • 7van der Laan S, Tsanov N, Crozet C, et al. Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency [ J]. Mol Cell, 2013, 52(3) :366-379.
  • 8van der Laan S, Golfetto E, Vanacker JM, et al. Cell cycle-de- pendent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells [ J/OL ]. PLoS One, 2014, 9 ( 4 ) [ 2015-06-07 ]. http :// www. ncbi. nlm. nih. gov/pmc/articles/PMC3973558.
  • 9Hayes SD, Harper JW. Cdc25A and Dub3 in a high-stakes bal- ancing act[J]. Nat Cell Biol, 2010, 12(4) :311-313.
  • 10Zhou B, Shu B, Xi T, et al. Dub3 expression correlates with tumor progression and poor prognosis in human epithelial ovarian cancer[ J]. Biomed Pharmacother, 2015, 70:84-89.

二级参考文献13

  • 1Kwong D, Sham J, Choy D, et al. The effect of Loco-regional control on diatant metastatic dissemination in carcinoma of the nasopharynx : a analysis of 1301 patients [ J ]. Int J Radiat Oncol Biol Phys,1994,30(5) :1029 -1036.
  • 2Mehra R, Cohen RB, Burtness BA. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck [ J ]. Clin Adv Hematol Oncol,2008,6(10) :742 -750.
  • 3Spano JP, Fagard R, Sofia JC, et al. Epidermal growth factor re- "ceptor signaling in colorectal cancer: preclinieal data and themp- eu-tic perspeetive[ J ]. Ann Onco1,2005,16 (2) : 189 - 194.
  • 4Watkins D, Cunningham D. The role of epidermal growth factor receptor-targeted antibody therapy in previouslytreated eoloreetal- cancer [ J ]. Clin Colorectal Cancer,2007,6 ( 2 ) :47 - 52.
  • 5Walsh L, Gillham C, Dunne M, et al. Toxicity of cctuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer( LAHNSCC ) [ J ]. Radiother On-eol,2011,98(1) :38 -41.
  • 6Sung FL,Poon TC, Hui EP, et al. Antitumor effect and enhance- ment of eytotoxic drug activity by cetuximab in nasopharyngeal carcinomacells [ J]. In Vivo,2005,19 ( 1 ) :237 - 245.
  • 7Huang SM, Bock JM, Harari PM. Epidermal growth factpr re- ceptor blocade with C225 modulates proliferation, apoptosis and radiosesitivity in squamous cell carcinomas of the head and neck [J]. Cancer Res, 1999,59(8) :1935 - 1940.
  • 8Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetux- imab treatment of locoregionally advanced head and neck cancer: One of phase ]lI study clinical trials's 5-year survival data and the relationship between cetuximab-induced rash and survival [ J ]. Lancet 0ncol.2010.11 ( 1 ) :21 - 28.
  • 9Chan AT, Hsu MM, Goh BC,et al. Multicenter phase lI study of cetuximab in combination with carboplatin in patients with recur- rent or metastatic nasopharyngeal carcinoma [ J ]..1 Clin Oncol, 2005, 23 (15) :3568 - 3576.
  • 10Koutcher L, Sherman E, Fury M, et al. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head and neck cancer [ J ]. Lnt J Raduat Otlcol Blot Phys,20 L 1 , 81 (4) :915 - 922.

共引文献15

同被引文献31

  • 1Siegel R L, Miller K D,Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin,2015,65(1) :5-29.
  • 2Koh W J, Greer B E, Abu-Rustum N R, et al. Cervical Canc- er,Version 2. 2015[J]. J Natl Compr Cane Netw, 2015, 13 (4) :395-404.
  • 3Zhao Z J, Ren H Y, Yang F, et al. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malig: nant plural effusion cells in human breast eancer[J]. Diagn Cytopathol, 2015,43(11) :897-903.
  • 4Yang K,Wang F, Han J J. TRAF4 promotes the growth and invasion of colon cancer through the Wnt/β-eatenin pathway[J]. Int J Clin Exp Pathol,2015,8(2) :1419-1426.
  • 5Ren H Y, Wang J, Yang F, et al. Cytoplasmie TRAF4 contrib- utes to the activation of p70s6k signaling pathway in breast eaneer[J]. Oneotarget, 2015,6 (6) : 4080-4096.
  • 6Chapard C, Hohl D, Huber M. The TRAF-interaeting protein (TRAIP)is a novel E2F target with peak expression in mito- sis[J]. 0ncotarget,2015,6(25) :20933-20945.
  • 7Huang L, Liu Q, Zhang L, et al. Encephalomyoearditis virus 3C protease relieves TRAF family member-associated NF-κB activator(TANK)inhibitory effect on TRAF6-rnediated NF- κB signaling through cleavage of TANK[J]. J Biol Chem, 2015,290(46) :27618-27632.
  • 8Yang J, Wei D, Wang W, et al. TRAF4 enhances oral squa- mous cell carcinoma cell growth, invasion and migration by Wnt-β-eatenin signaling pathway[J]. Int J Clin Exp Pathol, 2015,8(9) :11837-11846.
  • 9Yao W,Wang X,Cai Q, et al. Knockdown of TRAF4 expres- sion suppresses osteosarcoma cell growth in vitro and in vivo [J]. Int J Mol Med,2014,34(6) :1655-1660.
  • 10Chen T,Gao F,Feng S,et al. MieroRNA-370 inhibits the pro- gression of non-small cell lung cancer by downregulating on- eogeneTRAF4[J]. Oneol Rep,2015,34(1) :461-468.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部